Hepatoprotective for Children and Adolescent With Acute Lymphoblastic Leukemia
Launched by AIN SHAMS UNIVERSITY · Apr 6, 2025
Trial Information
Current as of October 30, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on protecting the liver in children and adolescents who have recently been diagnosed with acute lymphoblastic leukemia (ALL) and are starting their chemotherapy treatment. The research aims to monitor and prevent any liver damage that may occur during the early stages of chemotherapy. The study is currently looking for participants, specifically children and teenagers aged 2 to 18 years who are just beginning their treatment for ALL at Ain Shams Hospital.
To participate in this trial, children must be newly diagnosed with ALL and not have any known chronic liver diseases. If eligible, participants can expect to receive careful monitoring during their chemotherapy to help ensure their liver stays healthy throughout the treatment process. This study is important because it could lead to better care for young patients undergoing chemotherapy, helping to minimize potential side effects related to liver health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children and adolescents aged from 2 to 18 years newly diagnosed with acute lymphoblastic leukemia during induction phase of chemotherapy treated at Ain Shams
- Exclusion Criteria:
- • Known chronic liver disease.
About Ain Shams University
Ain Shams University, established in Cairo, Egypt, is a prestigious higher education institution renowned for its commitment to academic excellence and research innovation. As a clinical trial sponsor, the university leverages its extensive resources and expertise in various medical and scientific disciplines to advance healthcare through rigorous research initiatives. With a focus on ethical practices and adherence to regulatory standards, Ain Shams University aims to contribute to the development of new therapies and improve patient outcomes, fostering collaboration among researchers, healthcare professionals, and industry partners in the pursuit of medical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, Egypt
Cairo, Abbasia, Egypt
Patients applied
Trial Officials
Manal El-Sayed, MD
Study Chair
Faculty of Medicine Ain Shams University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported